samedan logo

 
 
spacer
home > ict > winter 2009 > capturing the impossible?
PUBLICATIONS
International Clinical Trials

Capturing the Impossible?

The world is changing, and the pharmaceutical and biotechnology landscapes are no different. The US and European markets are being out-paced and out-projected by new and emerging markets. Asia is leading the way, but African countries are rapidly positioning themselves to take up their place in this new world order.

Agencies such as the European and Developing Countries Clinical Trials Partnership (EDCTP), Malaria Clinical Trials Alliance (MCTA), Malaria Vaccine Initiative (MVI) and the Medicines for Malaria Venture (MMV) have all been established in order to manage the funding and execution of clinical research in developing countries, particularly in Africa, and especially for HIV/AIDS, tuberculosis and malaria.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Richard Young joined Cmed four years ago as Director of Data Management. Shortly afterwards, he moved into his current role as Director of Business Development. He has taken leadership roles in both Pharma and CRO environments, on both sides of the Atlantic, where he was responsible for developing and implementing various solutions for data capture and management. During the past two years, Richard has been heavily involved in implementing a number of challenging data collection/management strategies, ranging from adaptive trial design and eSource implementation to working in remote locations in the developing world.
spacer
Richard Young
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

Running Smarter Trials With Data-Driven Monitoring

PAREXEL

Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>

 
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement